C4 Therapeutics Inc. (CCCC) Social Stream



C4 Therapeutics Inc. (CCCC): $12.77

1.07 (+9.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CCCC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

C4 Therapeutics Inc (CCCC) Price Targets From Analysts

Use the tables below to see what analysts covering C4 Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 5 $75 $45 $59.333 $26.46 124.24%
2021-11-11 5 $75 $44 $59.166 $26.46 123.61%
2021-11-23 6 $75 $44 $58.714 $26.46 121.9%
2022-01-03 6 $84 $44 $60 $26.46 126.76%
2022-02-08 6 $84 $40 $56.142 $26.46 112.18%
2022-02-10 8 $84 $25 $52.25 $26.46 97.47%
2022-02-25 8 $84 $25 $52.5 $26.46 98.41%
2022-03-10 9 $84 $25 $49.666 $26.46 87.7%
2022-03-22 9 $84 $25 $48.777 $26.46 84.34%

The Trend in the Analyst Price Target


CCCC's average price target has moved down $8.72 over the prior 38 weeks.

Over the past 49 weeks, CCCC's average upside potential has been 59.91%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 1 60 51 56.500 32.66 72.99%
2021-07-17 5 64 51 57.500 39.95 43.93%
2021-08-07 5 64 51 57.500 37.68 52.6%
2021-11-11 6 75 44 59.166 42.92 37.85%
2022-02-25 8 84 25 52.500 22.76 130.67%

CCCC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


Over the past 28 days, CCCC's average broker recommendation rating improved by 0.06.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CCCC as an investment opportunity.

  • In the context of all US stocks, C4 Therapeutics Inc's variance in analysts' estimates is lower than -882.04% of them.
  • In terms of how C4 Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 957.72% of that group.
  • In the context of Pharmaceutical Products stocks, C4 Therapeutics Inc's average analyst price target is greater than 869.07% of them.
  • In the context of stocks in the mid market cap category, C4 Therapeutics Inc's number of analysts covering the stock is greater than 551.51% of them.

Stocks similar to C4 Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BEAM, BCRX, and BCAB.

Make investment decisions regarding CCCC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4533 seconds.